OTC Healthcare in Belarus
Euromonitor International's OTC Healthcare in Belarus market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 10 | Publication date: Jan 2007
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; Vitamins and dietary supplements; Wound treatments
Executive summary
Smoking cessation aids see strongest performance
There is a longstanding tradition of smoking in Belarus, particularly among men. However, in more recent times initiatives by the government to curb smoking, such as educational campaigns informing consumers of the dangers of tobacco, have stimulated demand for NRT smoking cessation aids. As a result these products saw the most dynamic performance in the country’s OTC healthcare market in 2005.
Lower growth in 2005 as government tackles inflation
While continuing to see notable growth throughout the OTC healthcare market in 2005, the increase seen in Belarus in current value terms was lower than the previous year, continuing the trend seen throughout the review period. This was due to efforts by the country’s government to combat inflation. In constant value terms the majority of products saw declines in 2005.
Distribution limitations a key factor
The government in Belarus maintains a firm grip on the country’s OTC healthcare industry, with the sale of such products only allowed through chemist outlets. No OTC healthcare products are available through other channels, such as supermarkets and hypermarkets or convenience stores. As a result of this policy there are no private label OTC healthcare products in the country. As a result price-sensitive consumers stick to purchases of low-priced products from local manufacturers.
Rural demand remains weak
The majority of OTC healthcare sales in Belarus occur in urban areas, where consumers are more affluent than their rural counterparts. Rural sales are also limited by the weak penetration of chemist outlets, which are often a considerable distance from consumers’ homes. Continued widespread use of traditional homemade remedies in rural areas also serves to stifle the potential for demand in such areas.
Non-essential products continue to perform poorly
Products such as eye and ear care saw particularly poor performances in 2005. This was due to a combination of relatively low incomes among the majority of consumers, and the fact that these items are considered non-essential. However, the forecast period is likely to see a moderate increase in consumer interest in such offerings as disposable incomes rise. For example, instead of giving children smaller doses of adult OTC healthcare products, parents are likely to move towards child-specific formulations.
Table of contents
OTC HEALTHCARE IN BELARUS : MARKET INSIGHT
1. EXECUTIVE SUMMARY
2. OPERATING ENVIRONMENT
2.1 OTC Registration and Classification
2.2 Vitamins & Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homeopathy
2.9 Generics
2.10 Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 2000-2005
2.11 Life Expectancy
Table 2 Life Expectancy at Birth 2000-2005
3. OTC HEALTHCARE SALES
3.1 Market Performance
Table 3 Retail Sales of OTC Healthcare by Sector: Value 2000-2005
Table 4 Retail Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
3.2 Competitive Environment
Table 5 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 6 OTC Healthcare Brand Shares by Retail Value 2002-2005
3.3 Leading Company Profile: Belmedpreparati
3.4 Leading Company Profile: Borisov Plant of Medical Preparations
3.5 New Product Developments
3.6 Retail Distribution
Table 7 Retail Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 8 Retail Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
3.7 Retailer Activity and Private Label Trends
3.8 Forecast Market Performance
Table 9 Forecast Retail Sales of OTC Healthcare by Sector: Value 2005-2010
Table 10 Forecast Retail Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
4. DEFINITIONS